Insider Trading & Ownership - Wargacki Stephen

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Wargacki Stephen

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-09
Tax Withholding(A)
2024-10-02
2:15 pm
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
Chief Science Officer
19,505$4.88261,414
(Direct)
View
2024-05-10
Option Award
2024-05-13
1:40 pm
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
Chief Science Officer
10,000$0267,963
(Direct)
View
2024-03-09
Tax Withholding
2024-03-12
1:46 pm
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
12,956$4.88257,963
(Direct)
View
2023-03-10
Tax Withholding
2024-03-11
10:34 am
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
1,981$0.7937327,169
(Direct)
View
2024-03-07
Option Award
2024-03-11
10:34 am
N/A
2034-03-07
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
168,750$0327,169
(Direct)
View
2023-08-09
Option Award
2023-08-09
4:30 pm
N/A
2026-05-05
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
67,500$067,500
(Direct)
View
2023-05-05
Option Award
2023-05-05
4:00 pm
N/A
2026-05-05
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
67,500$067,500
(Direct)
View
2023-03-09
Option Award
2023-03-09
3:06 pm
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
135,000$0161,956
(Direct)
View

Ownership
2023-01-11
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development
0$0125,456
(Direct)
View
(A) Indicate amendment filing.